There is consistent epidemiological evidence linking low birth weight, preterm birth and adverse fetal growth to an elevated risk of the metabolic syndrome (obesity, raised blood pressure, raised serum triglycerides, lowered serum high-density lipoprotein cholesterol and impaired glucose tolerance or insulin resistance) and related disorders. This "fetal or developmental origins/programming of disease" concept is now well accepted but the "programming" mechanisms remain poorly understood. We reviewed the major evidence, implications and limitations of current hypotheses in interpreting developmental programming and discuss future research directions. Major current hypotheses to interpret developmental programming include: (1) thrifty phenotype; (2) postnatal accelerated or catchup growth; (3) glucocorticoid effects; (4) epigenetic changes; (5) oxidative stress; (6) prenatal hypoxia; (7) placental dysfunction; and (8) reduced stem cell number. Some hypothetical mechanisms (2, 4 and 8) could be driven by other upstream "driver" mechanisms. There is a lack of animal studies addressing multiple mechanisms simultaneously and a lack of strong evidence linking clinical outcomes to biomarkers of the proposed programming mechanisms in humans. There are needs for (1) experimental studies addressing multiple hypothetical mechanisms simultaneously; and (2) prospective pregnancy cohort studies linking biomarkers of the proposed mechanisms to clinical outcomes or surrogate biomarker endpoints. A better understanding of the programming mechanisms is a prerequisite for developing early life interventions to arrest the increasing epidemic of the metabolic syndrome, type 2 diabetes and other related disorders.
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INTRODUCTION
The metabolic syndrome is commonly defined as a combination of at least three of the following five con ditions: obesity, elevated blood pressure, elevated serum triglycerides, low serum highdensity lipoprotein (HDL) cholesterol and impaired glucose tolerance or insulin resistance [1] . The clustering of these risk factors predis poses an individual to noninsulindependent (type 2) diabetes, cardiovascular morbidity and mortality. There is general consensus regarding the five components of the syndrome but definitions differ regarding cutoffs and mandatory criteria. Recently, central obesity [waist circumference > 102 cm in males or > 88 cm in females or body mass index (BMI) > 30] was proposed as a man datory component by the International Diabetes Fed eration [2] .
Epidemiological and experimental evidence suggest an association between an adverse prenatal environment and the risk of developing the metabolic syndrome and related disorders. This "fetal origins of disease" hypothesis was first proposed by Barker and Hales' group to explain the associations between low birth weight (LBW < 2500 grams) and increased risk of impaired glucose tolerance and cardiovascular disease in retrospective cohort studies [35] . Subsequent epidemiological studies in different populations largely confirmed this "fetal origins" phenomenon [38] . In recent years, the term "fetal origins/ programming" has been replaced by "developmental ori gins/programming" to accommodate the increasingly ac cepted concept that "programming" may continue in the early postnatal period.
A number of hypotheses have been proposed to interpret developmental programming [914] but none have received unanimous recognition. It is now worth reflecting on what is known about the mechanisms of developmental programming after decades of research. We critically reviewed the key evidence, implications and limitations of current hypotheses to interpret deve lopmental programming of the metabolic syndrome and discuss the directions for future research. The evidence acquisition was based on a literature review based on a PubMed search of publications between January 1970 and February 2010.
MAJOR HYPOTHESES
We use the term "major hypotheses" to refer to those supported by substantial epidemiological and experimental evidence. Two competing major hypotheses have been proposed: "thrifty phenotype" and "postnatal accelerated growth".
Thrifty phenotype
Rationale: Hales and Barker proposed the thrifty pheno type hypothesis ( Figure 1 ) [11, 12] . The hypothesis suggests that fetal and early postnatal malnutrition may induce poor development of pancreatic βcell mass. Malnutrition may have a selective impact on the growth of different organs with protection of the most vital (e.g. the brain). Because altered growth during critical periods permanently changes the structure and functional capacity of pancreatic βcell mass, such changes may "program" the metabolic system which increases the fetus' chance of survival in poor nu tritional environments but results in difficulty in coping with nutritional abundance later in life. The development of the metabolic syndrome following malnutrition in early life may depend on the superimposition of other postna tal risk factors, notably physical inactivity and obesity.
Epidemiological evidence: Barker and colleagues ob served in 1986 that the geographical distribution of heart disease in the United Kingdom was closely related to a person's place of birth [15] , suggesting that early life events could cause permanent changes in physiology predis posing to chronic heart disease. LBW has been strongly linked with impaired glucose tolerance and type 2 diabetes in adulthood [35, 1618] . Reduced fetal growth was related to increased plasma concentrations of 3233 split proinsu lin, a sign of betacell dysfunction [1921] , and was linked to high blood pressure [22, 23] . Children small in birth size may predispose to metabolic abnormalities upon exposure to postnatal environmental risk factors such as low physical activity and/or highenergy intake [24] . Prenatal exposure to famine during the Dutch Hunger Winter of 19441945 was associated with impaired glucose tolerance and insulin secretion in adulthood [25, 26] . The Pune Maternal Nutrition Study correlated prenatal specific micronutrient (vitamin B12) deficiency with increased insulin resistance in child hood [27] . Changes resulting from fetal and early postnatal malnutrition include: (1) metabolic adaptations in hepatic enzymes [28] , lipoprotein profiles [29] and clotting factors [30] ; (2) anatomical adaptations that affect endorgan glucose up take [31] and renal solute metabolism [32] ; and (3) endocrine 90 July 15, 2010|Volume 1|Issue 3| WJD|www.wjgnet.com adaptations that affect the hypothalamicpituitaryadrenal (HPA) axis [33] , insulin signaling [34] and leptin levels [35] . These changes could collectively lead to the metabolic syndrome and related disorders [36] .
Experimental evidence: In animal models, fetal mal nutrition has been associated with marked structural and physiological alterations [3739] . Gestational calorie restric tion and protein deprivation in rats led to hypertension in adult offspring [4042] and to altered glucose metabolism in sheep [43, 44] . Malnutritionassociated changes in fetal leptin levels may alter the programming of appetite and eating behaviors leading to an increased risk of cardio vascular and metabolic diseases [4548] . The pattern of dietary response of inbred mouse strains was similar to that expected under the thrifty phenotype hypothesis [49] . Permanent reductions in pancreatic cells and insulin secretion have been observed in proteinmalnourished fetuses [50] .
Implications and limitations:
The thrifty phenotype is the most widely accepted hypothesis to interpret devel opmental programming. The hypothesis emphasizes the etiological role of poor fetal and early postnatal nutrition and implicitly advocates promoting fetal and infant nu trition and growth [51] . It may well explain the increasing prevalence of obesity and type 2 diabetes in India and South Asian countries where malnutrition was previously common but has become less so in recent decades [52] . However, in virtually all human studies, maternal and fetal nutritional status, as determined either directly by specific nutrient biomarkers or indirectly by weight gain during pregnancy, were not available for linkage to clini cal outcomes. The hypothesis does not match the trends of increasing birth weights and declining LBW rates in many countries in recent decades [5355] , raising concerns as to whether poor fetal nutrition or "thrifty phenotype" is a major driver of developmental programming. Further more, poor fetal growth is a mere proxy for various peri natal insults. It is plausible that adverse insults may drive both poor fetal growth and developmental programming.
"Postnatal accelerated growth" or "catch-up growth" hypothesis
Rationale: The "postnatal accelerated growth" hypothesis was proposed by Drs. Singhal and Lucas to explain the association between faster early postnatal growth and surrogate endpoints in childhood and adolescence indi cative of metabolic and cardiovascular risks based on followups of preterm infants in two early neonatal fee ding/nutritional intervention trials [13, 14] . Increased infant growth rate by a nutrient enriched diet, even for only a few weeks postnatally, was associated with longterm adverse metabolic effects [68, 56] . Fasting concentrations of 3233 split proinsulin (a marker of insulin resistance) in adolescents born preterm were significantly elevated among those who had received a nutrientenriched diet in early postnatal life vs. placebo [7] . The authors concluded that early postnatal accelerated growth rather than pre maturity per se may be the culprit in programming insulin resistance and related disorders [14] .
Cianfarani proposed a similar "catchup growth" hypothesis [9] . At birth, infants with intrauterine growth retardation (IUGR) have low concentrations of insulin, insulinlike growth factor1 (IGF1) and insulinlike growth factor binding protein (IGFBP)3; and high con centrations of growth hormone, IGFBP1 and IGFBP2. Normalization of these hormones occurs during the first trimester of postnatal life [57, 58] . During this early pos tnatal catchup growth period when suddenly exposed to increased concentrations of insulin and IGF1, tissues chronically depleted of these two hormones during fetal life may counteract the hike by developing insulin resistance as a metabolic defense against developing hy poglycemia [9] . Therefore, IUGR infants who show early and complete growth recovery could be at higher risk for the occurrence of the metabolic syndrome in adulthood.
Dr. Gluckman proposed another similar hypothesis, the "predictive adaptive response" [10] . Based on the "pre dicted" postnatal environment, the fetus would make adaptations in utero or in the early postnatal period [10] . IUGR fetuses would thus predict a poor postnatal nutri tional environment. When mismatch occurred between predicted and actual, disease would manifest [10, 59] .
Epidemiologic evidence: Early childhood growth acce leration has been associated with later insulin resistance [60] , obesity [61] and cardiovascular disease [8] . In low birth weight infants, early growth acceleration has been associated with metabolic disturbances including dyslipidemia and elevated concentrations of insulin and IGF1 [9, 62, 63] . IUGR infants often experience compensatory accelerated growth after a period of poor fetal nutrition followed by the removal of such nutritional deficiency postnatally [64] . The most rapid growth occurs in early infancy [65] in the first few weeks after birth [66, 67] . Factors promoting neonatal growth such as enhanced neonatal nutrition could permanently affect or program longterm health [68] . Such accelerated growth may have adverse consequences later in life [64] , increase the propensity to cardiovascular disease [69] and its risk factors such as insulin resistance [70] , obesity [65] and higher blood pressure [71] . Patients with impaired glucose tolerance or diabetes typically had a low BMI in infancy, an early adiposity rebound in childhood and an accelerated in crease in BMI until adulthood [72] .
Experimental evidence:
In rats, accelerated early pos tnatal growth impaired glucose tolerance and shortened the lifespan [73] . Small neonatal rats temporarily overfed during the brief suckling period had permanent ele vations in plasma insulin and cholesterol levels in adul thood [74] . Postnatal accelerated growth can adversely affect glucose tolerance in rats [75] . Even in rats without IUGR, overfeeding during the brief suckling period per manently increased later plasma insulin and cholesterol concentrations [76, 77] with the propensity to obesity, high blood pressure and diabetes [53, 77] .
Implications and limitations:
An important implica tion of the "postnatal accelerated growth" or "catch up growth" hypothesis is that it questions the current practice of promoting postnatal catchup growth of small babies [14] . Enhancing infant growth rate by a nutrient enriched diet may actually do more harm than good in the long run. However, this hypothesis has been well tested only in preterm infants in Dr. Lucas's studies. It remains unclear whether the findings hold for catchup growth in IUGR infants born at term. The increasing birth weights in most countries in recent decades [54, 7880] indicate that there are unlikely substantial increases in the incidence of postnatal catchup growth. Consequently, it appears difficult to explain the substantial rise in the incidence of the metabolic syndrome. Also, the hypothesis does not match the epidemiological evidence of an elevated risk of the metabolic syndrome among macrosomic infants who often show catchdown rather than catchup growth during the early postnatal period.
MINOR HYPOTHESES
We use the term "minor hypotheses" to refer to those supported by insufficient research data, especially in hu mans.
Glucocorticoids programming
A product of the activation of the HPA axis, glucocor ticoids have potent effects on tissue development es pecially the maturation of organs such as the lung [81] . One outcome of fetal malnutrition is the exposure of the fetus to excess glucocorticoids which may restrict fetal growth and program the cardiovascular, endocrine and metabolic systems [82] . Normally, fetal glucocorticoid levels are much lower than maternal levels due to the placental barrier [83, 84] the placental enzyme 11βhydroxysteroid dehydrogenase type 2 (11βHSD2) catalyzes glucocorticoids (cortisol and corticosterone) into inert forms (cortisone, 11dehydro corticosterone) [80, 85] . However, synthetic glucocorticoids (betamethasone, dexamethasone) commonly administered to pregnant women at risk of preterm delivery to reduce neonatal pulmonary, renal and cerebral morbidities [86] , are poor substrates of 11βHSD2. Prenatal glucocorticoid overexposure through external sources or inhibition of placental 11βHSD2 may induce fetal HPA axis dys function a potential link between adverse fetal environ ment and insulin resistance and hypertension in adul thood [87] .
There is strong evidence of glucocorticoid program ming in animal models. Many studies have reported decreased birth weights and abnormal levels of plasma HPAaxis hormones in rats prenatally exposed to syn thetic glucocorticoids or inhibition of 11βHSD2 with increased blood pressures and glucose intolerance in adulthood [8789] . Hypertension in rats whose mothers were fed a lowprotein diet during pregnancy was prevent able by chemical blockade of maternal glucocorticoid synthesis [90] , suggesting that the link between maternal protein deprivation and adultonset hypertension may be mediated by maternal glucocorticoids. However, there is weak and inconsistent evidence regarding antenatal expo sure to synthetic glucocorticoids and components of the metabolic syndrome in humans. Studies have reported no change, slight increase or decrease in blood pressure [9194] . A Cochrane metaanalysis showed no differences in adult blood pressure [95] . In contrast, a recent followup study of 534 adults whose mothers had participated in a random ized controlled trial reported increased insulin resistance associated with antenatal betamethasone treatment [93] . LBW adults had much higher urinary glucocorticoid [96] and plasma cortisol concentrations [97] and showed greater responsiveness to adrenocorticotropic hormone [98, 99] . Pre natal glucocorticoids may be the link between LBW and increased risk of glucose intolerance and hypertension [87] . Elevated blood pressure after antenatal exposure to gluco corticoids may result from altered renal reninangiotensin system development [100] or from epigenetic changes affect ing the expression of specific transcription factors, espe cially the glucocorticoid receptor [87] .
However, there is a lack of strong evidence of gluco corticoid programming in humans. It remains unknown whether glucocorticoids drive both IUGR and the pro gramming of metabolic syndrome components as obser ved in animal models.
Epigenetic programming
Experimentally, transmission to the next generation of a "programmed" phenotype has been demonstrated for birth weight, metabolic dysfunction [101103] , blood pressure and vascular dysfunction [104] . Wild type mice born to hypertensive heterozygous nitric oxide synthase3 kno ckout mice displayed hypertension and vascular dysfunc tion [104] . Such transmission can be attributed to the fact that the programmed mother provided a deprived intrau terine environment, thus perpetuating the cycle of fetal (mal) adaptations. An alternate possibility is that epigenetic modification of the germline by stable DNA methylation or histone acetylation transmitted the prenatal experience of one generation to future generations. Many candidate and confirmed players able to induce developmental programming can modify gene methy lation. For example, Rees showed hypermethylation in the fetal liver of low protein fed dams [105] . Peroxisomal proliferatoractivated receptor (PPAR) alpha and glu cocorticoid receptor genes were hypomethylated and their expression increased in the liver of the offspring of proteinrestricted rats [106] . Reactive oxygen species can modify methylation leading to changes in gene transcrip tion and expression [107] . However, there are relatively little data demonstrating epigenetic changes after ad verse perinatal conditions in genes closely implicated in cardiovascular and metabolic disorders. Bogdarina reported modifications in the methylation status of the angiotensin Ⅱ AT1b receptor gene in the adrenal gland of the offspring of lowprotein fed dams [108] . Neonatal overfeeding in rats led to permanent dysregulation of the central circuitry of food intake inhibition with resistance to signals triggered by insulin and leptin [109111] . Circulating leptin and insulin stimulate the expression of the main anorexigenic neurohormone proopiomelanocortin (P OMC) while inhibiting the orexigenic neuropeptide Y [112, 113] . Plagemann recently demonstrated hypermethy lation of the hypothalamic POMC gene promoter regi on in neonatal overfeeding animals within two specific protein1 (Sp1) binding sequences. This led to blunted POMC expression despite hyperleptinemia and hyperi nsulinemia and demonstrated that a nutritionally acquired alteration of the methylation pattern could modify the set point of a gene promoter critical for body weight regu lation [114] .
The availability of methyl donor micronutrients may affect epigenetic programming. Dietary protein res triction in pregnancy induced and folic acid supple mentation prevented epigenetic modifications of he patic glucocorticoid receptor gene expression in rat offs pring [106] . Folate supplementation of lowprotein fed dams prevented elevation of blood pressure in adult offspring [115] . Restricting the supply of vitamin B12, folate and methionine even within normal physiological ranges during the periconceptional period was associated with widespread epigenetic alternations, insulin resistance and elevated blood pressure in sheep [116] . In contrast, ma ternal high folate status in pregnancy was associated with increased insulin resistance in children [27] , indicating the need for caution in applying results from animal models to humans. Dietary methyl supplementation with folic acid and B12 may have unintended deleterious consequences on epigenetic regulation [117] . More human data are needed in this nascent research area.
It should be pointed out that epigenetic programming is a physiological process in normal fetal development; the epigenetic changes dictate cell differentiation. The question is, are some epigenetic changes "pathological" secondary to certain perinatal insults? There is a lack of human data linking perinatal "programming" insults to developmental epigenetic changes and later risk of the metabolic syndrome and related disorders. Improved understanding of epigenetic changes may be helpful in designing interventions to prevent or possibly reverse adv erse programming.
Oxidative stress programming
Because many known or suspected causes of or conditions associated with adverse fetal growth or preterm birth have been associated with oxidative stress, it is plausible that oxidative stress may be the underlying common link to elevated risks of the metabolic syndrome [118] . Oxidative stress programming may act directly through modulation of gene expression (perhaps epigenetic) or indirectly via the effects of certain oxidized molecules. Experimental investigations have well demonstrated the role of redox balance in modulating gene expression [119, 120] . There is considerable experimental evidence indicating that both the insulin function axis and blood pressure regulation could be sensitive targets to oxidative stress programming during the prenatal and early postnatal periods [121126] . However, there remains a lack of epidemiological data relating biomarkers of perinatal oxidative stress to the metabolic syndrome. Validation of the oxidative stress hypothesis would suggest new early interventions to stem the modern epidemic of the metabolic syndrome.
Prenatal hypoxia programming
There is some evidence linking prenatal hypoxia to in creased vulnerability to metabolic and cardiovascular diseases [127] . Chronic hypoxia is a common insult to the fetus and reduced uteroplacental blood flow can result in fetal IUGR independently of malnutrition [128130] . Chr onic prenatal hypoxia has been shown to increase the susceptibility of the adult heart to ischemiareperfusion injury [131] . Human studies at high altitude also suggest that prenatal hypoxia can result in LBW [132134] . Chronic hypoxia has profoundly adverse effects on cardiac development and function in the fetus [129] and enhanced β1adrenergic receptor signaling may induce cardiomyocyte apoptosis via a protein kinase Adependent mechanism [132] . Animal studies show that chronic hypoxia could increase the hearttobody weight ratio in the fetus, suggesting an asymmetric growth of the heart [133] . Chronic hypoxia significantly increased the levels of cytochrome C, a mito chondrial marker protein, in the fetal heart [134] . The incre ased cytochrome C levels are likely a metabolic adaptation in the myocardium during asymmetric enlargement of the heart in hypoxic fetuses. Animal experiments showed that mitochondrial biogenesis played an important role in the early stages of cardiac hypertrophy [128] . Hypoxia could induce apoptosis in cultured neonatal rat cardio myocytes [135] . In response to chronic hypoxia during ges tation, many genes related to cell signaling and survival are down or upregulated in the fetal heart and other tissues [127] . No epidemiological data are available as to whether these effects are transient or permanent.
Placental dysfunction
It has been proposed that adult cardiovascular and me tabolic diseases originate via developmental plasticity and adaptations arising from failure of the maternalplacental nutrient supply to match fetal requirements [136] . This hypothesis emphasizes the role of the placenta in fetal programming. Maternal nutrition was associated with fetal development and programming of human cardiovascular and metabolic disease [137] . Maternal body composition and nutrition intake may affect fetal development by direct effects on substrate availability to the fetus and indirect effects via changes in placental function and structure [136] . Fetal adaptations may result from alterations in placental growth and vascular resistance, altered nutrient and hor mone metabolism in the placenta and changes in nutrient transfer and partitioning between mother, placenta and fetus [138140] . Fetal cardiovascular adaptations, alterations in fetal body composition and changes in fetal endo crinology and metabolism may have longterm effects on postnatal health. However, no data are available on the epidemiological associations between pathological placental changes and the metabolic syndrome in the of fspring. The hypothesis implies that improving placental function may have lifelong health benefits.
Reduced stem cell number
After organogenesis, the ability of cells to divide su bstantially for selfrenewal and repair is limited although some stem cells remain in various tissues in postnatal life. The stem cell hypothesis suggests that IUGR is associated with a reduced number of tissue stem cells, leading to an early exhaustion of organ function when demands are increased greatly [141] . The time windows for stem cell proliferation may represent critical periods. Diabetes patients often have fewer βcells prior to the onset of disease or the pancreas failed to generate more βcells in response to an increased demand for insulin [142] . In rats, fetal and neonatal nutritional deprivation caused permanent reductions in βcell mass and functional ef ficiency, resulting in glucose intolerance in adulthood [143] . IUGR induced by bilateral uterine artery ligation in preg nant rats caused postnatal glucose intolerance and insulin resistance in offspring; the βcells mass of IUGR rats was reduced by onethird [144] . There is a lack of data on stem cell number as it relates to metabolic syndrome pro gramming in humans.
OVER-NUTRITION PROGRAMMING?
Although most research is focused on adverse progra mming associated with poor fetal growth, there is evi dence that maternal overnutrition or fetal overgrowth may result in an offspring phenotype susceptible to the metabolic syndrome [145] . Maternal high fat or cholesterol overfeeding during pregnancy and lactation in rodents resulted in a phenotype of the offspring that closely resembled the human metabolic syndrome [145, 146] . Ges tational diabetes is associated with glucose oversupply to the fetus and consequently fetal macrosomia and may have adverse metabolic programming effects [147] . The effects of gestational diabetes seem independent of genetic factors [148] . Experimental evidence indicates that overnutrition may program obesity and metabolic syndrome through epigenetic changes [114] . A metaanalysis showed a Ushaped relationship between birth weight and type 2 diabetes risk in humans [149] . The hypothesis is concordant with the increasing birth weights over recent decades and may partly explain the increasing prevalence of the metabolic syndrome. It is unclear whether the effects of fetal overgrowth programming could be largely explained by impaired maternal glucose tolerance in humans.
CONCLUSION
The various hypotheses for interpreting developmental programming could be interrelated, indicating the need for research to address multiple mechanisms simultaneously. Some mechanisms could be driven by other "driver" mechanisms ( Figure 2 ). Multiple overarching drivers may exist: malnutrition, glucocorticoids, oxidative stress, pre natal hypoxia and placental dysfunction. These drivers may act alone or in combinations to induce epigenetic changes or reduce stem cell number, leading to the thrifty phenotype often followed by catchup growth and the propensity to metabolic syndrome. Thus, adverse pro gramming may occur in the absence of poor fetal growth.
The current prevailing theory is that fetal programming effects are magnified over the life course. However, the postnatal environment may either mask or magnify the true effects of programming the direction of effect modifications is unknown. The strongest evidence sup porting the various hypothetical mechanisms comes from animal models. However, we cannot assume that findings from animal models are applicable to humans as human pregnancy physiology is much more complex. For example, preeclampsia (gestational hypertension with proteinuria) is a gestational complication unique to humans [150] . Even the commonly used operating definitions for retarded or excessive fetal growth in hu mans are largely arbitrary and need reevaluations [151] . There is a need for studies to address multiple mecha nisms simultaneously in animal models and a need for prospective pregnancy cohort data linking intrauterine environmental biomarkers of the proposed programming mechanisms to clinical outcomes or surrogate biomarker endpoints in humans. A better understanding of the programming mechanisms is a prerequisite for developing early life interventions to halt the worldwide increasing epidemic of the metabolic syndrome, type 2 diabetes and other related disorders. 
